Publications by authors named "Alex F Herrera"

48Publications

Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis.

Clin Lymphoma Myeloma Leuk 2020 Dec 18. Epub 2020 Dec 18.

Division of Medical Oncology, Department of Internal Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article and Find Full Text PDF
December 2020

Highlights in Lymphoma From the 60th American Society of Hematology Annual Meeting: Commentary.

Authors:
Alex F Herrera

Clin Adv Hematol Oncol 2019 02;17 Suppl 4(2):20-23

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California.

View Article and Find Full Text PDF
February 2019

Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma.

Biol Blood Marrow Transplant 2019 12 5;25(12):2383-2387. Epub 2019 Aug 5.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Medical Oncology Division, University of Washington, Seattle, Washington.

View Article and Find Full Text PDF
December 2019

Noncellular Immune Therapies for Non-Hodgkin Lymphoma.

Authors:
Alex F Herrera

Hematol Oncol Clin North Am 2019 08 11;33(4):707-725. Epub 2019 May 11.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA. Electronic address:

View Article and Find Full Text PDF
August 2019

Relapsed and Refractory Classical Hodgkin Lymphoma: Keeping Pace With Novel Agents and New Options for Salvage Therapy.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:477-486. Epub 2019 May 17.

3 Lineberger Comprehensive Cancer Center, University of North Carolina - Chapel Hill, Chapel Hill, NC.

View Article and Find Full Text PDF
January 2019

CAR T cells mimicking an aggressive lymphoma.

Blood 2019 03;133(13):1517

City of Hope National Medical Center.

View Article and Find Full Text PDF
March 2019

Where does PD-1 blockade fit in HL therapy?

Authors:
Alex F Herrera

Hematology Am Soc Hematol Educ Program 2018 11;2018(1):213-220

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.

View Article and Find Full Text PDF
November 2018

Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis.

Biol Blood Marrow Transplant 2019 02 15;25(2):287-292. Epub 2018 Sep 15.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, California. Electronic address:

View Article and Find Full Text PDF
February 2019

Update on the role of brentuximab vedotin in classical Hodgkin lymphoma.

Ther Adv Hematol 2018 Sep 12;9(9):261-272. Epub 2018 Jul 12.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA 91010, USA.

View Article and Find Full Text PDF
September 2018

Updates on Circulating Tumor DNA Assessment in Lymphoma.

Curr Hematol Malig Rep 2018 10;13(5):348-355

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.

View Article and Find Full Text PDF
October 2018

Investigational Antibody-Drug Conjugates for Treatment of B-lineage Malignancies.

Clin Lymphoma Myeloma Leuk 2018 07 10;18(7):452-468.e4. Epub 2018 May 10.

Clinical Development and Regulatory, Sutro Biopharma, South San Francisco, CA.

View Article and Find Full Text PDF
July 2018

Current strategies for salvage treatment for relapsed classical Hodgkin lymphoma.

Ther Adv Hematol 2017 Oct 29;8(10):293-302. Epub 2017 Aug 29.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.

View Article and Find Full Text PDF
October 2017

Minimal Residual Disease Assessment in Lymphoma: Methods and Applications.

J Clin Oncol 2017 Dec 21;35(34):3877-3887. Epub 2017 Sep 21.

Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; and Philippe Armand, Dana-Farber Cancer Institute, Boston, MA.

View Article and Find Full Text PDF
December 2017

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.

J Clin Oncol 2017 Jan 24;35(1):24-31. Epub 2016 Oct 24.

Alex F. Herrera, Matthew Mei, Lawrence Low, Joo Y. Song, Victoria Bedell, Lithua Budde, Wing C. Chan, Robert Chen, Joyce Murata-Collins, Auayporn P. Nademanee, Raju Pillai, Leslie Popplewell, Tanya Siddiqi, Jasmine Zain, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Dennis D. Weisenburger, Young Kim, Amrita Krishnan, Tanya Paris, Tracey Stiller, Joycelynne M. Palmer, City of Hope National Medical Center, Duarte, CA; Haesook T. Kim, Jennifer R. Brown, Matthew S. Davids, Arnold S. Freedman, David C. Fisher, Eric D. Jacobsen, Caron A. Jacobson, Ann S. LaCasce, David M. Weinstock, Scott J. Rodig, Philippe Armand, Dana-Farber Cancer Institute; Gabriel K. Griffin, Reid W. Merryman, Christine Pak, Heather Sun, Brigham and Women's Hospital; German A. Pihan, Beth Israel Deaconess Medical Center; and Aliyah R. Sohani, Massachusetts General Hospital, Boston, MA.

View Article and Find Full Text PDF
January 2017

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

J Clin Oncol 2016 09 6;34(26):3141-9. Epub 2016 Jun 6.

Nilanjan Ghosh, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC; Reem Karmali, Rush University Medical Center; Sonali M. Smith, The University of Chicago, Chicago, IL; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Kwang Woo Ahn, Alyssa DiGilio, and Mehdi Hamadani, Medical College of Wisconsin & Center for International Blood and Marrow Transplant Research; Parameswaran N. Hari and Anita D'Souza, Medical College of Wisconsin; Timothy S. Fenske, Froedtert Memorial Lutheran Hospital, Milwaukee, WI; Veronika Bachanova, University of Minnesota Medical Center, Minneapolis, MN; Ulrike Bacher, University Medicine Goettingen and University Cancer Center Hamburg, Hamburg, Germany; Parastoo Dahi, Memorial Sloan Kettering Cancer Center-Adults, New York, NY; Marcos de Lima, University Hospitals Case Medical Center, Cleveland; Samantha Jaglowski, The Ohio State University Medical Center, Columbus, OH; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Tim D. Prestidge, Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; Bipin N. Savani, Vanderbilt University Medical Center, Nashville, TN; Anna M. Sureda, European Group for Blood and Marrow Transplantation and Hospital Duran I Reynals, Barcelona, Spain; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; Philippe Armand, Dana-Farber Cancer Institute, Boston, MA; Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA; and Nina D. Wagner-Johnston, Ephraim Fuchs, and Javier Bolaños-Meade, Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD.

View Article and Find Full Text PDF
September 2016

Double-Hit Lymphoma: Practicing in a Data-Limited Setting.

Authors:
Alex F Herrera

J Oncol Pract 2016 Mar;12(3):239-40

City of Hope Medical Center, Duarte, CA

View Article and Find Full Text PDF
March 2016

Ibrutinib for the treatment of mantle cell lymphoma.

Clin Cancer Res 2014 Nov;20(21):5365-71

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article and Find Full Text PDF
November 2014

A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.

Biol Blood Marrow Transplant 2014 Nov 10;20(11):1737-43. Epub 2014 Jul 10.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article and Find Full Text PDF
November 2014